Transcript Industry and Education Perfect Together

Innovative Program for STEM
Workforce Preparation
A ground breaking new path - An example of CSR
investment by the pharmaceutical industry in
education
• Developed for American High Schools, adaptable
for international implementation
• Educational model with unlimited possibilities for
adaptation to different areas of applied R&D
Project Description
Provides students with an understanding of how STEM is
applied in the making of new medicines through intense
research and development.
Builds understanding of R&D principles and processes
and prepares for knowledge transfer from school to work.
•
•
•
•
Integrates biology, chemistry, mathematics, social
sciences and language-arts
Breaks down barriers between subject areas
Adaptable to educational regional standards and
objectives
Focuses on development of skills in problem
identification, analysis, critical thinking, resource planning
and decision making, all within a framework of team work
Concept Transfer: Business to School
Pharmaceutical R&D
Research and Development
IDEA
HEALTHCARE
MARKETPLACE
High School
10:th-12:th Grade
Medicine & Science
Theory and Practice
PROBLEM SOLVING
Mathematical modeling,
Data handling & statistics
ANALYSIS
Strategic planning
Ethical considerations
CRITICAL THINKING
Resource mgmt; Finance
Market research and planning
DECISION MAKING
COLLABORATION WITHIN &
BETWEEN EXPERT TEAMS
Chemistry
Biology
Mathematics
Social Studies/
Health Care Policy
Language-Arts/
Communication
INTEGRATED LEARNING
AND SKILL DEVELOPMENT
Project Description
Phase 1 - Components:
•
•
•
•
•
•
•
Condensed program to teach elementary theory and practice
of pharmaceutical R&D with “deep dives” in biology,
chemistry, ethics and practical reality-based case examples
Sequence of eleven subject area lessons centered on inquiry
Laboratory experimentation
Rich – and growing roster of supplemental subject lessons
(Clinical trial design, statistical data analysis, mathematical
modeling of [pharmacodynamics and –kinetics, vaccine and
biologics development, etc.)
Teacher professional development (Summer Institute)
Active participation of pharmaceutical scientists
Independent evaluation
Course Overview
Lesson 1
Lesson 2
Lesson 3
Lesson 4
Lesson 5
Lesson 6
Lesson 7
Lesson 8
Lesson 9
Lesson 10
Introduction
Discovery
Discovery
Discovery
Preclin. Development
Preclin. Development
Clinical R&D
Clinical R&D
Clinical R&D
Commercialization
Lesson 11 Marketing
Diseases and Their Impact
Targets and Magic Bullets
Screening for Solutions
The Power of Molecules
Chromatography Separation
Selecting the Best Molecule
IND and Phase I
Phase II
Phase III and NDA
Exploring the Business of
Science and Medicine
Where Business & Science
Overlap
Pharmaceutical R&D
Key facts
Broadens understanding of the pharmaceutical R&D
process
•
•
•
•
•
•
Developing a new medicine can take more than 12
years, costs $1+ billion
R&D is complex, involves many steps, many
potential obstacles and decision points
High risk investment – High benefit for human health
Costs must be recouped to invest in next life-saving
or life-enhancing drug
Safe and effective medicines reduce overall
healthcare costs
Government regulation assures quality control
Project Team
Program Lead:
PhRMA & NSRC
Steering Committee:
•
•
•
•
•
•
PhRMA members:
Bristol-Myers Squibb
GlaxoSmithKline
Johnson &Johnson
Novartis
Schering-Plough
Roche
Wyeth
Twenty-one Schools in Twelve SDs in NJ, NY, MA, PA and IA
NJ Department of Education
Healthcare Institute of New Jersey
Biological Sciences Curriculum Study (evaluation)
Museum of Contemporary Science
Phase I Conclusion
Summer Institute 2007
•
Five-day Teacher Training event, hosted by BMS and
Montgomery School District
– Opening Day with Dinner Keynote by Sally Shuler, NSRC
– Master Class Institute at Montgomery HS
– Pharmaceutical Roundtable with partner company
representation
– District implementation plans logged in
– Laboratory kits distributed to all participant schools
– Teacher stipends paid by partner companies
•
•
•
Nineteen teams participated with 59 teachers
Five pharmaceutical companies, DoEd, HINJ
Press availability and favorable media coverage
2007 Summer Institute
Evaluation
As a result of participating in the Summer Institute…
• Teachers have a significantly better understanding of
 the extent, and complexity of pharmaceutical R&D,
 the social and economical issues faced by the industry,
and
 career opportunities for qualified talent
•
Teachers have a significantly stronger familiarity with the
RxeSEARCH curriculum,
 how it connects to and reflects the R&D process, and
 the advantage it offers to inter-disciplinary teaching
and learning of applied STEM
•
Teachers are confident that they can implement
RxeSEARCH in their schools, and believe that the
curriculum will positively influence student learning
Outcomes Objectives
Key Stakeholders
PRIVATE SECTOR
• Broaden understanding of the R&D process. Provide facts
about the quest for new leads to make better medicines
• Create student interest & readiness for industry careers
• Demonstrate corporate social responsibility
• Strengthen relationship with grassroots community
SOCIETY/GENERAL PUBLIC
• Provide a new model for
demonstrating relevance of
STEM* to students’ lives
• Prepare students for 21st
century jobs
• Strengthen the high-school
experience to make it globally
competitive through applied
learning
PUBLIC EDUCATION SECTOR
• Broaden understanding of the scientific enterprise
and its real-world applications
• Heighten motivation for further study of STEM*
• Provide deep understanding and mastery of content
• Develop authentic, in depth skills in problem-solving, analysis
and critical thinking through integrated learning
*STEM: Science, Technology, Engineering, Mathematics